Literature DB >> 21784755

Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

Jacob G Scott, David Basanta, Prakash Chinnaiyan, Peter Canoll, Kristen R Swanson, Alexander R A Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21784755      PMCID： PMC3223086          DOI： 10.1093/neuonc/nor083

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  21 in total

1.  Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

Authors:  Meghan J Seltzer; Bryson D Bennett; Avadhut D Joshi; Ping Gao; Ajit G Thomas; Dana V Ferraris; Takashi Tsukamoto; Camilo J Rojas; Barbara S Slusher; Joshua D Rabinowitz; Chi V Dang; Gregory J Riggins
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

2.  Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.

Authors:  Tatsuhiro Shibata; Akiko Kokubu; Masashi Miyamoto; Yuko Sasajima; Naoya Yamazaki
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  Metabolic modulation of glioblastoma with dichloroacetate.

Authors:  E D Michelakis; G Sutendra; P Dromparis; L Webster; A Haromy; E Niven; C Maguire; T-L Gammer; J R Mackey; D Fulton; B Abdulkarim; M S McMurtry; K C Petruk
Journal:  Sci Transl Med       Date:  2010-05-12       Impact factor: 17.956

4.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Authors:  Christian Hartmann; Bettina Hentschel; Wolfgang Wick; David Capper; Jörg Felsberg; Matthias Simon; Manfred Westphal; Gabriele Schackert; Richard Meyermann; Torsten Pietsch; Guido Reifenberger; Michael Weller; Markus Loeffler; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2010-11-19       Impact factor: 17.088

5.  The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.

Authors:  David Basanta; Jacob G Scott; Russ Rockne; Kristin R Swanson; Alexander R A Anderson
Journal:  Phys Biol       Date:  2011-02-07       Impact factor: 2.583

6.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

7.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

8.  Recurring mutations found by sequencing an acute myeloid leukemia genome.

Authors:  Elaine R Mardis; Li Ding; David J Dooling; David E Larson; Michael D McLellan; Ken Chen; Daniel C Koboldt; Robert S Fulton; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Devin P Locke; Vincent J Magrini; Rachel M Abbott; Tammi L Vickery; Jerry S Reed; Jody S Robinson; Todd Wylie; Scott M Smith; Lynn Carmichael; James M Eldred; Christopher C Harris; Jason Walker; Joshua B Peck; Feiyu Du; Adam F Dukes; Gabriel E Sanderson; Anthony M Brummett; Eric Clark; Joshua F McMichael; Rick J Meyer; Jonathan K Schindler; Craig S Pohl; John W Wallis; Xiaoqi Shi; Ling Lin; Heather Schmidt; Yuzhu Tang; Carrie Haipek; Madeline E Wiechert; Jolynda V Ivy; Joelle Kalicki; Glendoria Elliott; Rhonda E Ries; Jacqueline E Payton; Peter Westervelt; Michael H Tomasson; Mark A Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Daniel C Link; Matthew J Walter; Timothy A Graubert; John F DiPersio; Richard K Wilson; Timothy J Ley
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

9.  2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.

Authors:  Genglin Jin; Zachary J Reitman; Ivan Spasojevic; Ines Batinic-Haberle; Jian Yang; Oleg Schmidt-Kittler; Darell D Bigner; Hai Yan
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.752

Review 10.  Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

Authors:  Nanne K Kloosterhof; Linda B C Bralten; Hendrikus J Dubbink; Pim J French; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2010-07-07       Impact factor: 54.433
View more
  5 in total

1.  Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas.

Authors:  Sanne A M van Lith; Remco Molenaar; Cornelis J F van Noorden; William P J Leenders
Journal:  Neuro Oncol       Date:  2014-07-28       Impact factor: 12.300

Review 2.  Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology.

Authors:  Jessica A Scarborough; Jacob G Scott
Journal:  Semin Radiat Oncol       Date:  2022-01       Impact factor: 5.421

Review 3.  Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective.

Authors:  Peter DelNero; Young Hye Song; Claudia Fischbach
Journal:  Biomed Microdevices       Date:  2013-08       Impact factor: 2.838

4.  Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Authors:  Anne L Baldock; Kevin Yagle; Donald E Born; Sunyoung Ahn; Andrew D Trister; Maxwell Neal; Sandra K Johnston; Carly A Bridge; David Basanta; Jacob Scott; Hani Malone; Adam M Sonabend; Peter Canoll; Maciej M Mrugala; Jason K Rockhill; Russell C Rockne; Kristin R Swanson
Journal:  Neuro Oncol       Date:  2014-06       Impact factor: 12.300

5.  Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival.

Authors:  Yu Yao; Aden Ka-Yin Chan; Zhi Yong Qin; Ling Chao Chen; Xin Zhang; Jesse Chung-Sean Pang; Hiu Ming Li; Yin Wang; Ying Mao; Ho-Keung Ng; Liang Fu Zhou
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.752
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.